209 related articles for article (PubMed ID: 8626874)
41. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas.
Klugbauer S; Rabes HM
Oncogene; 1999 Jul; 18(30):4388-93. PubMed ID: 10439047
[TBL] [Abstract][Full Text] [Related]
42. [Rearrangement of the RET gene in papillary thyroid carcinoma].
Wiench M; Włoch J; Oczko M; Gubała E; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():64-71. PubMed ID: 12182064
[TBL] [Abstract][Full Text] [Related]
43. The ret/PTC1 rearrangement is a common feature of Chernobyl-associated papillary thyroid carcinomas from Belarus.
Pisarchik AV; Ermak G; Fomicheva V; Kartel NA; Figge J
Thyroid; 1998 Feb; 8(2):133-9. PubMed ID: 9510121
[TBL] [Abstract][Full Text] [Related]
44. The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas.
Cetta F; Chiappetta G; Melillo RM; Petracci M; Montalto G; Santoro M; Fusco A
J Clin Endocrinol Metab; 1998 Mar; 83(3):1003-6. PubMed ID: 9506763
[TBL] [Abstract][Full Text] [Related]
45. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
[TBL] [Abstract][Full Text] [Related]
46. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
[TBL] [Abstract][Full Text] [Related]
47. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.
Fusco A; Chiappetta G; Hui P; Garcia-Rostan G; Golden L; Kinder BK; Dillon DA; Giuliano A; Cirafici AM; Santoro M; Rosai J; Tallini G
Am J Pathol; 2002 Jun; 160(6):2157-67. PubMed ID: 12057919
[TBL] [Abstract][Full Text] [Related]
48. Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas.
Pierotti MA; Bongarzone I; Borrello MG; Mariani C; Miranda C; Sozzi G; Greco A
J Endocrinol Invest; 1995 Feb; 18(2):130-3. PubMed ID: 7629380
[No Abstract] [Full Text] [Related]
49. A novel type of RET rearrangement (PTC8) in childhood papillary thyroid carcinomas and characterization of the involved gene (RFG8).
Klugbauer S; Jauch A; Lengfelder E; Demidchik E; Rabes HM
Cancer Res; 2000 Dec; 60(24):7028-32. PubMed ID: 11156407
[TBL] [Abstract][Full Text] [Related]
50. RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas.
Learoyd DL; Messina M; Zedenius J; Guinea AI; Delbridge LW; Robinson BG
J Clin Endocrinol Metab; 1998 Oct; 83(10):3631-5. PubMed ID: 9768676
[TBL] [Abstract][Full Text] [Related]
51. Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma.
Salassidis K; Bruch J; Zitzelsberger H; Lengfelder E; Kellerer AM; Bauchinger M
Cancer Res; 2000 Jun; 60(11):2786-9. PubMed ID: 10850414
[TBL] [Abstract][Full Text] [Related]
52. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL
Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089
[TBL] [Abstract][Full Text] [Related]
53. RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions.
Collins BJ; Chiappetta G; Schneider AB; Santoro M; Pentimalli F; Fogelfeld L; Gierlowski T; Shore-Freedman E; Jaffe G; Fusco A
J Clin Endocrinol Metab; 2002 Aug; 87(8):3941-6. PubMed ID: 12161537
[TBL] [Abstract][Full Text] [Related]
54. RET rearrangements in familial papillary thyroid carcinomas.
Corvi R; Lesueur F; Martinez-Alfaro M; Zini M; Decaussin M; Murat A; Romeo G
Cancer Lett; 2001 Sep; 170(2):191-8. PubMed ID: 11463498
[TBL] [Abstract][Full Text] [Related]
55. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma.
Smanik PA; Furminger TL; Mazzaferri EL; Jhiang SM
Hum Mol Genet; 1995 Dec; 4(12):2313-8. PubMed ID: 8634704
[TBL] [Abstract][Full Text] [Related]
56. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation.
Mizuno T; Iwamoto KS; Kyoizumi S; Nagamura H; Shinohara T; Koyama K; Seyama T; Hamatani K
Oncogene; 2000 Jan; 19(3):438-43. PubMed ID: 10656692
[TBL] [Abstract][Full Text] [Related]
57. Molecular defects in thyroid carcinomas: role of the RET oncogene in thyroid neoplastic transformation.
Santoro M; Grieco M; Melillo RM; Fusco A; Vecchio G
Eur J Endocrinol; 1995 Nov; 133(5):513-22. PubMed ID: 7581978
[TBL] [Abstract][Full Text] [Related]
58. Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas.
Fluge O; Haugen DR; Akslen LA; Marstad A; Santoro M; Fusco A; Varhaug JE; Lillehaug JR
Oncogene; 2001 Feb; 20(7):885-92. PubMed ID: 11314023
[TBL] [Abstract][Full Text] [Related]
59. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
Grieco M; Santoro M; Berlingieri MT; Melillo RM; Donghi R; Bongarzone I; Pierotti MA; Della Porta G; Fusco A; Vecchio G
Cell; 1990 Feb; 60(4):557-63. PubMed ID: 2406025
[TBL] [Abstract][Full Text] [Related]
60. Different significance of ret/PTC(1) and ret/PTC(3) rearrangements in thyroid carcinogenesis: lesson from two subgroups of patients with papillary thyroid carcinomas showing the highest incidence of ret/PTC activation.
Cetta F; Gori M; Montalto G; Zuckermann M; Toti P
J Clin Endocrinol Metab; 2001 Mar; 86(3):1429. PubMed ID: 11238550
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
